Results 211 to 220 of about 703,828 (371)

Validation and psychometric evaluation of the Swedish version of the Nasal Obstruction Symptom Evaluation scale. [PDF]

open access: yesLaryngoscope Investig Otolaryngol, 2023
Sunnergren O   +5 more
europepmc   +1 more source

Effect and Threshold of Endoscopic Findings for CRS Control Status and Long‐Term Outcome Prediction

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background EPOS 2020 defined chronic rhinosinusitis (CRS) disease control using patient symptoms and medication usage but endoscopic findings were considered optional. The effect of adding endoscopic features, an appropriate threshold, and their association with present or future symptom control have not been studied.
Steven Chun‐Kang Liao   +14 more
wiley   +1 more source

A rare case of ancient schwannoma of nasal vestibule causing complete nasal obstruction: A case report and brief review of literature. [PDF]

open access: yesInt J Surg Case Rep
Reta BK   +5 more
europepmc   +1 more source

Translation and Validation of the Thai Version of the Nasal Obstruction Symptom Evaluation (NOSE) Scale. [PDF]

open access: yesOTO Open, 2023
Prasertwit K   +4 more
europepmc   +1 more source

Mechanisms of Mitochondrial Toxicity and Cytotoxicity Caused by Pseudomonas aeruginosa Pyocyanin in Human Nasal Epithelial Cells

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Pseudomonas aeruginosa is an opportunistic pathogen in cystic fibrosis‐related chronic rhinosinusitis (CF‐CRS) that produces phenazine metabolites pyocyanin and 1‐hydroxyphenazine (1‐HP), which may have detrimental effects on mitochondria, reactive oxygen species (ROS), Ca2+ signaling, and apoptosis.
Joel C. Thompson   +8 more
wiley   +1 more source

Comparison of Cottle-Area-2 and Cottle-Area-3 in Computed Tomography Scans of Patients with Nasal Obstruction and Controls. [PDF]

open access: yesDiagnostics (Basel)
Heppt H   +5 more
europepmc   +1 more source

Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Loss of smell is a principal symptom of chronic rhinosinusitis with nasal polyps (CRSwNP), affecting health‐related quality of life and posing a safety hazard. Methods WAYPOINT (NCT04851964), a phase 3, multicenter trial in adults with uncontrolled CRSwNP, randomized patients 1:1 to receive tezepelumab 210 mg or placebo ...
Joaquim Mullol   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy